BICD2 - dominant spinal muscular atrophy

This test is available for the following conditions:

  • Conditions > Renal / Nephrological > Congenital dominant spinal muscular atrophy

This product is also part of the following panels:

  • Fetal akinesia panel
  • Heart disorders panel¹
  • Intellectual disability panel with genome wide CNV analysis
  • Mendelian inherited disorders panel with genome wide CNV analysis
  • Muscle disorders panel
  • Neuropathies panel¹

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 609797
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 394

Gene

BICD2 - dominant spinal muscular atrophy

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 394

BICD2 - dominant spinal muscular atrophy



€ 394